Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations

Archives of Dermatology

Volumn 142, Issue 12, 2006, Pages 1591-1597

  Leslie, Kieron S ^a   Lachmann, Helen J ^b,d   Bruning, Elizabeth ^d,e   McGrath, John A ^d,e   Bybee, Alison ^b   Gallimore, J Ruth ^b   Roberts, Philip F ^f   Woo, Patricia ^c   Grattan, Clive E ^f   Hawkins, Philip N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Amyloidosis Centre   (United Kingdom)

^c Windeyer Institute   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; ANTIHISTAMINIC AGENT; AZATHIOPRINE DERIVATIVE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; GENE PRODUCT; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN NALP3; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THALIDOMIDE;

ADULT; AUTOINFLAMMATORY DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FEVER; GENOTYPE; HISTOPATHOLOGY; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE STINGING; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEPHROTIC SYNDROME; NEUTROPHIL CHEMOTAXIS; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; REMISSION; REVIEW; TREATMENT RESPONSE; URTICARIA; VASODILATATION;

ADOLESCENT; ADULT; CARRIER PROTEINS; CHILD; DNA; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MUTATION, MISSENSE; PHENOTYPE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URTICARIA;

EID: 33845686908     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.12.1591     Document Type: Review

References (24)

1. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301-305.
2. Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis [published correction appears in Arthritis Rheum. 2002;46:3398]. Arthritis Rheum. 2002;46:2445-2452.
3. Kile RL, Rusk HA. A case of cold urticaria with an unusual family history. JAMA. 1940;114:1067-1068.
4. Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235-248.
5. Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr. 1981;99:79-83.
6. Granel B, Philip N, Serratrice J, et al. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes. Dermatology. 2003;206:257-259.
7. Lokuta MA, Cooper KM, Aksentijevich I, Kastner DL, Huttenlocher A. Neutrophil chemotaxis in a patient with neonatal-onset multisystem inflammatory disease and Muckle-Wells syndrome. Ann Allergy Asthma Immunol. 2005;95:394-399.
8. Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340-3348.
9. Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71:198-203.
10. Martinon F, Hofmann K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol. 2001;11:R118-R120.
11. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4:95-104.
12. Gumucio DL, Diaz A, Schaner P, et al. Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol. 2002;20(suppl 26):S45-S53.
13. Stack JH, Beaumont K, Larsen PD, et al. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol. 2005;175:2630-2634.
14. Dinarello CA. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme. Ann N Y Acad Sci. 1998;856:1-11.
15. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003;348:2583-2584.
16. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998;35:745-753.
17. Expert Committee on Biological Standardization, 37th Report. Geneva, Switzerland: World Health Organization; 1987:21-22. WHO Technical Report Series 760.
18. Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA): evaluation in an international collaborative study. J Immunol Methods. 1998;214:1-10.
19. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis. 1991;89:137-141.
20. 123I-labeled serum amyloid P component. N Engl J Med. 1990; 323:508-513.
21. Lieberman A, Grossman ME, Silvers DN. Muckle-Wells syndrome: case report and review of cutaneous pathology. J Am Acad Dermatol. 1998;39:290-291.
22. Kilcline C, Shinkai K, Bree A, Modica R. Von Scheven E. Frienden IJ. Neonatalonset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol. 2005;141:248-253.
23. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med. 1999;37:381-388.
24. Sanocka D, Jedrzejczak P, Szumala-Kaekol A, Fraczek M, Kurpisz M. Male genital tract inflammation: the role of selected interleukins in regulation of prooxidant and antioxidant enzymatic substances in seminal plasma. J Androl. 2003;24:448-455.